Administrative Core

行政核心

基本信息

  • 批准号:
    10595065
  • 负责人:
  • 金额:
    $ 26.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-21 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY (ADMINISTRATIVE CORE) The Administrative Core will lead SEA-TRAC and assume responsibility for strategic planning and operational management. Aim 1 is focused on enabling the conduct of the best TB science and the development of the next generation of TB research leaders. This will be accomplished in three subaims. First, we will define, implement, and continuously refine our strategic plan by regularly convening our multi-disciplinary leadership team and obtaining and implementing feedback from our user community and Internal and External Advisory Committees. Second, we will promote an environment to grow collaboration and respond to emerging needs. This will be accomplished through seminars, workshops, and conferences that bring our diverse community together to learn and foster dialogue that will lead to new collaborations and funding applications. Third, we will engage in inter-TRAC initiatives by working with the NIAID as well as bi-directional connections to the community by working with partners, such as Treatment Action Group, to increase public awareness of TB as a global health problem. In Aim 2, we will provide operational management that ensures ‘added value’ to our TB research enterprise. This will be accomplished in four subaims. First, we will manage TRAC Cores and Scientific Working Groups (SWGs) by continuously evaluating and redefining Core utilization and managing the pre- and post- award process for Developmental Project Awards. Second, we will ensure effective communication between the Leadership Group, TRAC Members, and Core Users to develop and promote services that add value to our research enterprise. We will also facilitate communication with NIAID as well as other TRACs. Third, we will facilitate increased funding and support for TRAC Members by continuing to advocate on their behalf for increased institutional commitments as well as working with external partners whose mission align with ours. Finally, we will manage TRAC finances and personnel by establishing and executing rigorous policies and procedures governing the allocation of funds, compliance monitoring, personnel management, and maintenance of TRAC Member and Core user databases. As described in the Overall Strategy, the Vision of SEA-TRAC is to facilitate a decrease in the global burden of TB through training and high-impact multi-disciplinary research. The Administrative Core will ensure strategic, effective, and efficient leadership to achieve this goal.
项目概要(行政核心) 行政核心将领导东南欧-TRAC,并负责战略规划和 业务管理。目标1的重点是使最好的结核病科学和发展的行为, 下一代结核病研究领导者。这将在三个次级目标中实现。首先,我们将定义, 通过定期召开我们多学科领导会议,实施并不断完善我们的战略计划 团队,并从我们的用户社区和内部和外部咨询中获取和实施反馈 委员会。第二,我们将促进一个有利于加强合作和应对新需求的环境。 这将通过研讨会、讲习班和会议来实现, 共同学习和促进对话,这将导致新的合作和资金申请。三是 通过与NIAID合作以及与社区的双向联系,参与TRAC之间的倡议 通过与治疗行动小组等合作伙伴合作,提高公众对结核病作为全球健康问题的认识, 问题.在目标2中,我们将提供业务管理,确保我们的结核病研究“增值” 企业.这将在四个次级目标中实现。首先,我们将管理TRAC核心和科学工作 通过持续评估和重新定义核心利用率以及管理 发展项目奖的颁奖过程。第二,我们将确保 领导小组、TRAC成员和核心用户开发和推广服务,为我们的 研究企业。我们还将促进与NIAID以及其他TRAC的沟通。三是 * 通过继续代表TRAC成员国倡导,促进增加对它们的供资和支助, 加强机构承诺,并与使命与我们一致的外部伙伴合作。 最后,我们将通过制定和执行严格的政策, 管理资金分配、合规性监测、人员管理和维护的程序 TRAC成员和核心用户数据库。如《总体战略》所述,东南欧方案核心预算资源调拨目标的愿景是 通过培训和高影响力的多学科研究,促进减少全球结核病负担。 行政核心将确保战略性、有效和高效的领导,以实现这一目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHETAN SESHADRI其他文献

CHETAN SESHADRI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHETAN SESHADRI', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10425946
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
脂质特异性 T 细胞在介导结核分枝杆菌保护中的作用
  • 批准号:
    10415830
  • 财政年份:
    2020
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
脂质特异性 T 细胞在介导结核分枝杆菌保护中的作用
  • 批准号:
    10633190
  • 财政年份:
    2020
  • 资助金额:
    $ 26.36万
  • 项目类别:
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens
测量人类 T 细胞对分枝杆菌脂质抗原反应的测定方法的资格
  • 批准号:
    9312745
  • 财政年份:
    2016
  • 资助金额:
    $ 26.36万
  • 项目类别:
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens
测量人类 T 细胞对分枝杆菌脂质抗原反应的测定方法的资格
  • 批准号:
    9152421
  • 财政年份:
    2016
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
  • 批准号:
    8312393
  • 财政年份:
    2010
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
  • 批准号:
    8127625
  • 财政年份:
    2010
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
  • 批准号:
    8510564
  • 财政年份:
    2010
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
  • 批准号:
    8719921
  • 财政年份:
    2010
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
  • 批准号:
    7959293
  • 财政年份:
    2010
  • 资助金额:
    $ 26.36万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 26.36万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 26.36万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 26.36万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 26.36万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 26.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了